期刊文献+

mTOR信号通路和肿瘤治疗 被引量:5

mTOR signaling pathway:a target for cancer therapy
原文传递
导出
摘要 PI3K蛋白激酶类家族的mTOR作为信号传导分子,在细胞的生长、增殖、分化和凋亡等许多生理过程中起着重要的控制作用,笔者就其信号通路的构成以及其上、下游信号的特点作一概述,并初步阐明mTOR信号通路与肿瘤治疗的关系。 As a signaling transducer, mTOR, one member of the PI3K family, plays an important role in regulation of a variety of physiological functions involving cell growth, proliferation, differentiation and apoptosis etc. This paper overviews the composition of mTOR signaling complexes and the specific functions of the molecules up- and down-stream, and briefly elucidates the role ofmTOR signaling pathway in cancer therapy.
作者 赵凡 李灼日
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第2期204-208,共5页 China Journal of General Surgery
关键词 肿瘤/治疗 哺乳动物雷帕霉素靶蛋白 信号传导 综述文献 Neoplasms/ther Mammalian Target of Rapamycin Signal Transduction Review
  • 相关文献

参考文献2

二级参考文献143

  • 1Gao N,Zhang Z,Jiang BH,et al.Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer[J].Biochem Biophys Res Commun,2003,310(4):1124-1132.
  • 2Vogt PK.PI 3 -kinase,mTOR,protein synthesis and cancer[J].Trends Mol Med,2001,(7)11:482 -484.
  • 3Findlay GM,Harrington LS,Lamb RF.TSC-2 tumor suppressor and regulation of mTOR signaling:linking cell growth and proliferation?[J].Curr Opin Genet Dev,2005,15(1):69 -76.
  • 4Huang S,Houghtom PJ.Targeting mTOR signaling for cancer therapy[J].Curr Opin Phamacol,2003,3(4):371 -377.
  • 5Xu G,Zhang W,Bertram P,et al.Pharmacogenomic profiling of the PI3 K/PTEN-AKT-mTOR pathway in common human tumor[J].Int J Oncol,2004,24(4):901 -908.
  • 6Gao X, Zhang Y, Arrazola P, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 2002; 4:699-704.
  • 7Potter C J, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002; 4:658-665.
  • 8Goncharova EA, Goncharov DA, Eszterhas A, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 2002; 277:30958-30967.
  • 9Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4:648-657.
  • 10Potter C J, Huang H, Xu T. Drosophila Tsc I functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 2001; 105:357-368.

共引文献62

同被引文献71

  • 1刘民锋,罗剑,余险峰,唐启彬,陈勇军,邹声泉.PTEN和mTOR信号转导通路在胆管癌发展中作用的研究[J].中国普通外科杂志,2006,15(4):274-276. 被引量:13
  • 2董崇海,曲玲,赵清喜,李杰,郭春霞,刁春艳,王德仙.散发性结直肠癌、腺瘤组织中hMLH1和突变型p53表达[J].中国肿瘤,2007,16(2):123-126. 被引量:7
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J].CA Cancer J Clin, 2005, 55(2):74-108.
  • 4Kawahara N, Ono M, Tagunhi K, et al. Enhanced expressionof thromhospondin-1 and hypovasnularity in humancholangiocarcinoma[J]. Hepatology, 1998, 28(6):1512-1517.
  • 5Smith CL, Birdsey GM, Anthony S, et al. Dimethylargininedimethylaminohydrolase activity modulates ADMA levels, VEGFexpression, and cell phenotype[J]. Biochem Biophys Res Commun,2003, 308(4):984-989.
  • 6Baha HA, Wohlschlaeger J, Cicinnati VR, et al. Phosphorylation ofp70S6 kinase predicts overall survival in patients with clear margin-resented hepatocellular carcinoma[J]. Liver Int, 2009, 29(3):399-405.
  • 7Zhou L, Huang Y, Li J, et al. The mTOR pathway is associatedwith the. poor prognosis of human hepatocellular c,arcinoma[J], MedOncol, 2010, 27(2):255-261.
  • 8Semela D, Piguet AC, Kolev M, et al. Vascular remodelingand antitumoral effects of mTOR inhibition in a rat model ofhepatocellular carcinoma[J]. J Hepatol, 2007,46(5):840-848.
  • 9Chang Z, Shi G, Jin J, et al. Dual PI3K/mTOR inhibitor N VP-BEZ235-itiduced apoptosis of hepatocellular carcinoma cell linesis enhanced hy inhibitors of autophagy[J]. Int J Mol Med, 2013,31(6):1449-1456.
  • 10Cridelli C, Malone P, Rossi A. The potential role of mTOR inhibitorsin non-small cell lung cancer[J]. Oncologist, 2008, 13(2):139-147.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部